Search research articles
Contact Us
Filters
Showing results (311-320 of 429) with videos related to
Page
of 43
Sort By:
Journal of Neurology
|
July 25, 2024
United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use
Ali A Habib, Andrew J Klink, Srikanth Muppidi, et al.
Journal of Neurology
|
June 3, 2026
Clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis: subgroup analyses from a randomized, double‑blind, placebo‑controlled, phase 3 trial (ADAPT)
James F Howard, Francesco Saccà, Sarah Hoffmann, et al.
Expert Opinion on Investigational Drugs
|
April 1, 2021
Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis
James F Howard, John Vissing, Nils E Gilhus, et al.
Journal of Neurology
|
February 24, 2024
Improvement of fatigue in generalised myasthenia gravis with zilucoplan
Michael D Weiss, Miriam Freimer, M Isabel Leite, et al.
Drugs - Real World Outcomes
|
October 29, 2024
US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization
Richard J Nowak, Ali A Habib, Andrew J Klink, et al.
The Journal of Pediatrics
|
November 13, 2018
Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series
Luke Arthur, Kirsty Keen, Madeleine Verriotis, et al.
European Journal of Neurology
|
April 17, 2025
Long-Term Efficacy and Safety of Ravulizumab in Adults With Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-Label Extension
Tuan H Vu, Renato Mantegazza, Djillali Annane, et al.
Applied Microbiology and Biotechnology
|
November 1, 2016
Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL
Mandy Larson, Angela Toepp, Benjamin Scott, et al.
Blood
|
July 4, 2001
Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia
K A Tolba, W J Bowers, S P Hilchey, et al.
Plos One
|
September 29, 2017
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment
Faria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, et al.
Page
of 43
Search research articles
Search
Showing results (311-320 of 429) with videos related to
Sort By:
Page
of 43
Journal of Neurology
|
July 25, 2024
United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use
Ali A Habib, Andrew J Klink, Srikanth Muppidi, et al.
Journal of Neurology
|
June 3, 2026
Clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis: subgroup analyses from a randomized, double‑blind, placebo‑controlled, phase 3 trial (ADAPT)
James F Howard, Francesco Saccà, Sarah Hoffmann, et al.
Expert Opinion on Investigational Drugs
|
April 1, 2021
Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis
James F Howard, John Vissing, Nils E Gilhus, et al.
Journal of Neurology
|
February 24, 2024
Improvement of fatigue in generalised myasthenia gravis with zilucoplan
Michael D Weiss, Miriam Freimer, M Isabel Leite, et al.
Drugs - Real World Outcomes
|
October 29, 2024
US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization
Richard J Nowak, Ali A Habib, Andrew J Klink, et al.
The Journal of Pediatrics
|
November 13, 2018
Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series
Luke Arthur, Kirsty Keen, Madeleine Verriotis, et al.
European Journal of Neurology
|
April 17, 2025
Long-Term Efficacy and Safety of Ravulizumab in Adults With Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-Label Extension
Tuan H Vu, Renato Mantegazza, Djillali Annane, et al.
Applied Microbiology and Biotechnology
|
November 1, 2016
Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL
Mandy Larson, Angela Toepp, Benjamin Scott, et al.
Blood
|
July 4, 2001
Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia
K A Tolba, W J Bowers, S P Hilchey, et al.
Plos One
|
September 29, 2017
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment
Faria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, et al.
Page
of 43